Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Hideto Tamura

Showing results (21-30 of 70) with videos related to

Pageof 7
Sort By:
Journal of Leukocyte Biology|July 9, 2002
Selective expansion of perforin-positive CD8+ T cells by immature dendritic cells infected with live Bacillus Calmette-Guérin mycobacteriaYasuko Tsunetsugu-Yokota, Hideto Tamura, Mikiko Tachibana, et al.
Zhongguo Shi Yan Xue Ye Xue Za Zhi|April 26, 2014
Effect of G-CSF on induction of ENA-78 and IL-8 in the patients with malignant lymphomaWan-Hong Zhao, Shan Meng, Hideto Tamura, et al.
Immunobiology|December 9, 2019
A combination of check-point blockade and α-galactosylceramide elicits long-lasting suppressive effects on murine hepatoma cell growth in vivoKazuhito Ishii, Masumi Shimizu, Hideki Kogo, et al.
Japanese Journal of Clinical Oncology|April 11, 2018
Elotuzumab-induced interstitial lung disease: the first case reportToru Tanaka, Yoshinobu Saito, Nariaki Kokuho, et al.
Oncology Letters|January 7, 2022
CD155 and CD112 as possible therapeutic targets of <i>FLT3</i> inhibitors for acute myeloid leukemiaYuta Kaito, Mitsuhito Hirano, Muneyoshi Futami, et al.
Journal of Gastroenterology and Hepatology|August 30, 2011
Ribavirin downmodulates inducible costimulator on CD4+ T cells and their interleukin-10 secretion to assist in hepatitis C virus clearanceMasanori Atsukawa, Katsuhisa Nakatsuka, Tamaki Kobayashi, et al.
Molecular Cancer Therapeutics|April 21, 2021
Durvalumab Combined with Immunomodulatory Drugs (IMiD) Overcomes Suppression of Antitumor Responses due to IMiD-induced PD-L1 Upregulation on Myeloma CellsMariko Ishibashi, Junichi Yamamoto, Takumi Ito, et al.
Stem Cells (Dayton, Ohio)|April 26, 2005
Identification and hematopoietic potential of CD45- clonal cells with very immature phenotype (CD45-CD34-CD38-Lin-) in patients with myelodysplastic syndromesKiyoyuki Ogata, Chikako Satoh, Mikiko Tachibana, et al.
Immunology|August 16, 2012
Ribavirin modulates the conversion of human CD4(+)  CD25(-) T cell to CD4(+)  CD25(+)  FOXP3(+) T cell via suppressing interleukin-10-producing regulatory T cellTamaki Kobayashi, Katsuhisa Nakatsuka, Masumi Shimizu, et al.
The Journal of Clinical Investigation|February 21, 2002
Blockade of LIGHT/LTbeta and CD40 signaling induces allospecific T cell anergy, preventing graft-versus-host diseaseKoji Tamada, Hideto Tamura, Dallas Flies, et al.
Pageof 7

Showing results (21-30 of 70) with videos related to

Sort By:
Pageof 7
Journal of Leukocyte Biology|July 9, 2002
Selective expansion of perforin-positive CD8+ T cells by immature dendritic cells infected with live Bacillus Calmette-Guérin mycobacteriaYasuko Tsunetsugu-Yokota, Hideto Tamura, Mikiko Tachibana, et al.
Zhongguo Shi Yan Xue Ye Xue Za Zhi|April 26, 2014
Effect of G-CSF on induction of ENA-78 and IL-8 in the patients with malignant lymphomaWan-Hong Zhao, Shan Meng, Hideto Tamura, et al.
Immunobiology|December 9, 2019
A combination of check-point blockade and α-galactosylceramide elicits long-lasting suppressive effects on murine hepatoma cell growth in vivoKazuhito Ishii, Masumi Shimizu, Hideki Kogo, et al.
Japanese Journal of Clinical Oncology|April 11, 2018
Elotuzumab-induced interstitial lung disease: the first case reportToru Tanaka, Yoshinobu Saito, Nariaki Kokuho, et al.
Oncology Letters|January 7, 2022
CD155 and CD112 as possible therapeutic targets of <i>FLT3</i> inhibitors for acute myeloid leukemiaYuta Kaito, Mitsuhito Hirano, Muneyoshi Futami, et al.
Journal of Gastroenterology and Hepatology|August 30, 2011
Ribavirin downmodulates inducible costimulator on CD4+ T cells and their interleukin-10 secretion to assist in hepatitis C virus clearanceMasanori Atsukawa, Katsuhisa Nakatsuka, Tamaki Kobayashi, et al.
Molecular Cancer Therapeutics|April 21, 2021
Durvalumab Combined with Immunomodulatory Drugs (IMiD) Overcomes Suppression of Antitumor Responses due to IMiD-induced PD-L1 Upregulation on Myeloma CellsMariko Ishibashi, Junichi Yamamoto, Takumi Ito, et al.
Stem Cells (Dayton, Ohio)|April 26, 2005
Identification and hematopoietic potential of CD45- clonal cells with very immature phenotype (CD45-CD34-CD38-Lin-) in patients with myelodysplastic syndromesKiyoyuki Ogata, Chikako Satoh, Mikiko Tachibana, et al.
Immunology|August 16, 2012
Ribavirin modulates the conversion of human CD4(+)  CD25(-) T cell to CD4(+)  CD25(+)  FOXP3(+) T cell via suppressing interleukin-10-producing regulatory T cellTamaki Kobayashi, Katsuhisa Nakatsuka, Masumi Shimizu, et al.
The Journal of Clinical Investigation|February 21, 2002
Blockade of LIGHT/LTbeta and CD40 signaling induces allospecific T cell anergy, preventing graft-versus-host diseaseKoji Tamada, Hideto Tamura, Dallas Flies, et al.
Pageof 7